Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. I. Restrepo, L. Copeland, M. J. Pugh, A. Anzueto, E. M. Mortensen (San Antonio, United States Of America). Late Breaking Abstract: Angiotensin II receptor blocker is associated with lower mortality in hospitalized patients with pneumonia. Eur Respir J 2010; 36: Suppl. 54, 4614

Member's Comments

No comment yet.

Related content which might interest you: Effect of angiotensin II receptor antagonists on cardiovascular disorders in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001 Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Late Breaking Abstract - The neurokinin-1 receptor antagonist orvepitant improves chronic cough symptoms: results from a Phase 2b trial Source: International Congress 2019 – Highlights in lung function and chronic cough Year: 2019 Late Breaking Abstract - Pneumonectomy in patients with reduced pulmonary function: complications and 30-day mortality Source: International Congress 2019 – General thoracic surgery Year: 2019 LATE-BREAKING ABSTRACT: Angiotensin II receptor 1 blocker (Losartan) restores the ability of the lung to clear edema in rats. Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Impact of blockers of AT1 receptors to angiotensin II on endothelium vasoregulating function in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 739s Year: 2006 Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Cardiohemodynamics changes in COPD patients while using blockers of AT1 receptors to angiotensin II Source: Eur Respir J 2006; 28: Suppl. 50, 105s Year: 2006 Evaluation in administration of angiotensin II receptor antagonist Valsartan in the treatment of hypertension patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Severe pneumonia mortality in pediatric patients is associated with downregulation of Toll-like receptors 2 and 4 on monocytes Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments Year: 2016 Late Breaking Abstract - Inhaled corticosteroids in bronchiectasis is associated to increased morbidity, Pseudomonas colonization and mortality – a five-year prospective cohort study Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Association of outpatient statin, ARB, and ACE inhibitor use on clinical outcomes for elderly subjects hospitalized with severe sepsis Source: Annual Congress 2013 –Interesting research questions Year: 2013 Late Breaking Abstract - Corticosteroids reduce mortality and prevent ICU admission in Covid-19 pneumonia – results from a rapid clinical review of 191 patients Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Why low risk class CURB patients with CAP are hospitalized? Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Angiotensin II receptor blockers, ACE inhibitors, lung function and percent emphysema; the MESA lung study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Inpatients with PSI III community-acquired pneumonia: are low or high risk patients? Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Late Breaking Abstract - CPAP is effective in treating COVID-19 patients with Type 1 respiratory failure. Source: Virtual Congress 2020 – Nasal high flow and non-invasive ventilation in acute and chronic care Year: 2020